| Obesity is a risk factor for developing critical condition in COVID‐19 patients: a systematic review and meta‐analysis M Földi, N Farkas, S Kiss, N Zádori, S Váncsa, L Szakó, F Dembrovszky, ... Obesity Reviews 21 (10), e13095, 2020 | 296 | 2020 |
| Metabolic associated fatty liver disease is associated with an increased risk of severe COVID-19: a systematic review with meta-analysis PJ Hegyi, S Váncsa, K Ocskay, F Dembrovszky, S Kiss, N Farkas, B Erőss, ... Frontiers in medicine 8, 626425, 2021 | 70 | 2021 |
| The negative impact of comorbidities on the disease course of COVID-19 N Zádori, S Váncsa, N Farkas, P Hegyi, B Erőss, ... Intensive care medicine 46, 1784-1786, 2020 | 62 | 2020 |
| EASY‐APP: An artificial intelligence model and application for early and easy prediction of severity in acute pancreatitis B Kui, J Pintér, R Molontay, M Nagy, N Farkas, N Gede, Á Vincze, J Bajor, ... Clinical and translational medicine 12 (6), e842, 2022 | 45 | 2022 |
| Inositol is an effective and safe treatment in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials D Greff, AE Juhász, S Váncsa, A Váradi, Z Sipos, J Szinte, S Park, P Hegyi, ... Reproductive Biology and Endocrinology 21 (1), 10, 2023 | 32 | 2023 |
| Repeated SARS-CoV-2 positivity: analysis of 123 cases S Váncsa, F Dembrovszky, N Farkas, L Szakó, B Teutsch, S Bunduc, ... Viruses 13 (3), 512, 2021 | 32 | 2021 |
| Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on angiotensin-converting enzyme 2 levels: a comprehensive analysis based on animal studies G Kriszta, Z Kriszta, S Vancsa, PJ Hegyi, L Frim, B Erőss, P Hegyi, ... Frontiers in pharmacology 12, 619524, 2021 | 32 | 2021 |
| Sarcopenia–2021 A Pár, JP Hegyi, S Váncsa, G Pár Orvosi hetilap 162 (1), 3-12, 2021 | 31 | 2021 |
| Fatty liver disease and non-alcoholic fatty liver disease worsen the outcome in acute pancreatitis: a systematic review and meta-analysis S Váncsa, D Németh, P Hegyi, Z Szakács, PJ Hegyi, D Pécsi, A Mikó, ... Journal of clinical medicine 9 (9), 2698, 2020 | 31 | 2020 |
| Glucose levels show independent and dose-dependent association with worsening acute pancreatitis outcomes: Post-hoc analysis of a prospective, international cohort of 2250 … A Nagy, MF Juhász, A Görbe, A Váradi, F Izbéki, Á Vincze, P Sarlós, ... Pancreatology 21 (7), 1237-1246, 2021 | 25 | 2021 |
| Pre-transplant sarcopenic obesity worsens the survival after liver transplantation: a meta-analysis and a systematic review PJ Hegyi, A Soós, P Hegyi, Z Szakács, L Hanák, S Váncsa, K Ocskay, ... Frontiers in Medicine 7, 599434, 2020 | 22 | 2020 |
| Pre-existing liver diseases and on-admission liver-related laboratory tests in COVID-19: a prognostic accuracy meta-analysis with systematic review S Váncsa, PJ Hegyi, N Zádori, L Szakó, N Vörhendi, K Ocskay, M Földi, ... Frontiers in Medicine 7, 743, 2020 | 22 | 2020 |
| Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation: A systematic review and meta-analysis A Szabó, S Váncsa, P Hegyi, A Váradi, A Forintos, T Filipov, J Ács, N Ács, ... Reproductive Biology and Endocrinology 21 (1), 5, 2023 | 21 | 2023 |
| Early prediction of acute necrotizing pancreatitis by artificial intelligence: a prospective cohort-analysis of 2387 cases S Kiss, J Pintér, R Molontay, M Nagy, N Farkas, Z Sipos, P Fehérvári, ... Scientific reports 12 (1), 7827, 2022 | 20 | 2022 |
| Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis–An international cohort study A Demcsák, A Soós, L Kincses, I Capunge, G Minkov, ... Pancreatology 20 (7), 1323-1331, 2020 | 19 | 2020 |
| Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta–analysis S Bunduc, N Gede, S Váncsa, V Lillik, S Kiss, F Dembrovszky, B Eross, ... Critical Reviews in Oncology/Hematology 169, 103548, 2022 | 15 | 2022 |
| Alcohol consumption and smoking dose-dependently and synergistically worsen local pancreas damage A Szentesi, N Farkas, Z Sipos, P Mátrai, Á Vincze, F Izbéki, A Párniczky, ... Gut 71 (12), 2601-2602, 2022 | 14 | 2022 |
| New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial D Illés, E Ivány, G Holzinger, K Kosár, MG Adam, B Kamlage, G Zsóri, ... BMJ open 10 (11), e037267, 2020 | 13 | 2020 |
| Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis Á Széles, T Fazekas, S Váncsa, M Váradi, PT Kovács, U Krafft, ... Cancer Immunology, Immunotherapy 72 (5), 1061-1073, 2023 | 12 | 2023 |
| Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis S Bunduc, N Gede, S Váncsa, V Lillik, S Kiss, MF Juhász, B Erőss, ... Translational Research 244, 126-136, 2022 | 12 | 2022 |
Peter HegyiProfessor of Medicine, Semmelweis University (SE, full time) & Pécs (PTE, part time), HungaryVerified email at semmelweis-univ.hu
